John G. Brain

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].

Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].

Journal: Journal of hepatology

Published: July 06, 2026

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice.

Anti-Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct-Ligated Mice.

Journal: The American journal of pathology

Published: May 20, 2022

A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4.

A neutrophil-B-cell axis impacts tissue damage control in a mouse model of intraabdominal bacterial infection via Cxcr4.

Journal: eLife

Published: March 01, 2022

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study.

Journal: EBioMedicine

Published: November 23, 2021

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis.

Journal: Hepatology (Baltimore, Md.)

Published: January 08, 2021

TGF-β2 silencing to target biliary-derived liver diseases.

TGF-β2 silencing to target biliary-derived liver diseases.

Journal: Gut

Published: May 15, 2019

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation.

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation.

Journal: FASEB bioAdvances

Published: October 29, 2018

Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Author Correction: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Journal: Nature

Published: July 06, 2018

Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Erratum: Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Journal: Nature

Published: November 24, 2017

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity.

Journal: Nature

Published: November 10, 2016

Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis.

Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis.

Journal: Oncology letters

Published: November 01, 2016

Early Molecular Stratification of High-risk Primary Biliary Cholangitis.

Early Molecular Stratification of High-risk Primary Biliary Cholangitis.

Journal: EBioMedicine

Published: October 10, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026